Trial intelligence / Profile preview

Sodium bicarbonate Ringer's versus normal saline in sepsis

ChiCTR2100053514Phase 4Not yet recruiting

Sponsor
People's Hospital of Jiangdu
Start
Jan 2022
Modality
Small Molecules, Implantable Devices → Device-based Delivery → Drug Delivery Systems, Transdermal Patches → Device-based Delivery → Drug Delivery Systems
Countries
1
01

Overview

Phase 4, open-label trial of sodium bicarbonate ringer's solution and Normal Saline-Benha University in sepsis (2 arms), sponsored by People's Hospital of Jiangdu. Primary endpoint: 30-day mortality. Planned start Jan 2022; status: not yet recruiting.

02

Drugs

sodium bicarbonate ringer's solutionNormal Saline-Benha University
03

Conditions

sepsis

Beyond the preview

Go deeper on ChiCTR2100053514.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2100053514.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call